The company focuses on meeting the critical needs of people living with cancer, starting from childhood cancer biology. They prioritize bringing rapid treatment options to market for both young and old patients. Day One Biopharmaceuticals aims to license and acquire promising products from research institutions and other biotech and pharmaceutical companies. Founded in 2018 and headquartered in South San Francisco, the company leverages advances in cancer research to identify patients who may benefit from the same medicine, providing a unique approach to improving lives.